<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is an important cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Prediction of recurrence is an important issue in the treatment of disease, particularly for stage II patients </plain></SENT>
<SENT sid="2" pm="."><plain>The level of telomere-specific reverse transcriptase (hTERT), the catalytic component of the telomerase complex, increases along with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression, but its prognostic value is still unclear </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: One hundred and thirty-seven <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients were studied for hTERT expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells by real-time PCR </plain></SENT>
<SENT sid="4" pm="."><plain>hTERT level was evaluated as a prognostic factor of overall survival (OS) in <z:hpo ids='HP_0000001'>all</z:hpo> patients and of disease recurrence in a subgroup of 50 stage II patients </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The median hTERT level was 93.8 copies (interquartile range 48-254) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with high hTERT levels (above the median) showed a significantly worse survival than those with low hTERT levels (below the median; log-rank test P&lt;0.0001; hazard ratio (HR)=3.30 (95% confidence interval (CI) 1.98-5.52); P&lt;0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>The negative prognostic value of high hTERT level is independent of the pathological stage and microsatellite instability (HR=2.09 (95% CI 1.20-3.64), P=0.009) </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, in stage II <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, high hTERT levels identified patients with a higher risk of disease recurrence (HR=3.06 (95% CI 1.03-9.04), P=0.043) and <z:hpo ids='HP_0011420'>death</z:hpo> (HR=3.24 (95% CI 1.37-7.71), P=0.008) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: hTERT level is an independent prognostic marker of OS in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, assessment of hTERT level could improve stratification of stage II <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients for the risk of disease recurrence </plain></SENT>
</text></document>